Toulouse hosts 3rd Biopharma Outsourcing meeting
The 3rd edition of the Biopharma Outsourcing meeting will take place in Toulouse this year. The meeting covers all aspects of service, competence and product sourcing and outsourcing for pharmaceutical and biotech companies.
A meeting that focuses on new types of collaboration
The purpose of the meeting is to answer the constantly evolving needs of buyers and outsourcers in biotech and pharmaceutical companies. In this sector, outsourcing practices evolve quickly and need to be reviewed every 6 months to keep up with the specific needs of buyers and outsourcers, who need to find new ways to interact with suppliers, subcontractors, collaborators and co-developers. The Biopharma Outsourcing meeting focuses on exchanges of best practices between participants to provide new solutions.
An all-round biopharma event
The meeting centers around question sessions, testimonials and solutions at all stages of the outsourcing process to create sustainable businesses. This year, a special masterclass will be organized for small expert working groups who wish to explore new ways to offer their services and products to buyers, account managers and outsourcers. The Biopharma Outsourcing meeting also alternates conferences and company presentations in order to promote new solutions. Special “shaker interaction” sessions are scheduled to stimulate discussions between participants during round table debates on specific subjects. The meeting also includes direct interactions as well as formal and informal networking opportunities.
Physiostim in the spotlight
PhysioStim is pleased to announce our presence at the Biopharma Outsourcing meeting on October 9th and 10th, 2017. Marie Le Grand, our very own CEO, is scheduled as a speaker on the afternoon of October 9th on the following theme: “Buyers and CROs, a matter of teamwork in cardiovascular safety pharmacology”. Other companies have also announced their presence: CiToxLab, GTP Technology, VWR International, Tebu-Bio, Sanofi Pasteur, and many more.
Comments are closed.